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Abstract
Purpose: X-ray micro-computed tomography (μCT) is a widely used imaging modality in preclinical
research with applications in many areas including orthopedics, pulmonology, oncology, cardiology,
and infectious disease. X-rays are a form of ionizing radiation and, therefore, can potentially induce
damageand cause detrimental effects. Previous reviews have touched on these effects but have not
comprehensively covered the possible implications on study results. Furthermore, interpreting data
across these studies is difficult because there is no widely accepted dose characterization
methodology for preclinical μCT. The purpose of this paper is to ensure in vivo μCT studies can be
properly designed and the data can be appropriately interpreted.
Procedures: Studies from the scientific literature that investigate the biological effects of radiation
doses relevant to μCT were reviewed. The different dose measurement methodologies used in the
peer-reviewed literature were also reviewed. The CT dose index 100 (CTDI100) was then measured
on the Quantum GX μCT instrument. A low contrast phantom, a hydroxyapatite phantom, and a
mouse were also imaged to provide examples of how the dose can affect image quality.
Results: Data in the scientific literature indicate that scenarios exist where radiation doses used
in μCT imaging are high enough to potentially bias experimental results. The significance of this
effect may relate to the study outcome and tissue being imaged. CTDI100 is a reasonable metric
to use for dose characterization in μCT. Dose rates in the Quantum GX vary based on the
amount of material in the beam path and are a function of X-ray tube voltage. The CTDI100 in air
for a Quantum GX can be as low as 5.1 mGy for a 50 kVp scan and 9.9 mGy for a 90 kVp scan.
This dose is low enough to visualize bone both in a mouse image and in a hydroxyapatite
phantom, but applications requiring higher resolution in a mouse or less noise in a low-contrast
phantom benefit from longer scan times with increased dose.
Conclusions: Dose management should be considered when designing μCT studies. Dose rates
in the Quantum GX are compatible with longitudinal μCT imaging.
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Introduction
The field of medical imaging utilizes many different imaging
and detection methodologies. Magnetic resonance imaging,
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ultrasound, and optical imaging do not use ionizing radiation,
and are generally considered to be safe. However, radiation
dose can become a concern in the nuclear and X-ray-based
imaging modalities that use ionizing radiation. Ionizing
radiation can have a range of acute, latent, and genetic effects
with clinical outcomes ranging frommild sickness to sterility to
acute illness with early death [1]. Previous reviews have also
investigated clinically relevant radiation-induced cancer and
skeletal changes that can occur [2, 3].
X-ray micro-computed tomography (μCT) is an imaging
modality that is widely used to image both hard and soft
tissues for studies in orthopedics, pulmonology, oncology,
cardiology, radiology, and infectious disease [4–7]. By
directing the X-ray beam at tissue and placing a detector
on the opposite side, an image can be created that is directly
related to the absorption and scatter within tissue (due to the
photoelectric effect and Compton scatter) that leave energy
behind in the tissue, creating the dose. Unfortunately, there
is no single accepted unit for X-ray dose. Previous studies
have used Roentgens (R), Sieverts (Sv), Gray (Gy), radiation
absorbed dose (rad), and Roentgen equivalent man (REM)
[1, 8]. Irrespective of which unit is used, several fundamen-
tal physical concepts contribute to dose. The inverse square
law states that dose is inversely proportional to the square of
the distance between the source and object. The linear
attenuation coefficient is energy dependent, and commonly
used sources have a polychromatic X-ray spectrum, so dose
is proportional to the sum of all photons absorbed at energies
in the spectrum being used. Mathematically, combining
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where
E = X-ray photon energy
r = distance between source and object
NE = # of absorbed photons for a given energy
L = path length that X-rays travel through tissue
μ(E) = linear attenuation coefficient
The inclusion of L and μ in this relationship indicates that
there is some dependence on the object itself. The linear
attenuation μ(E) is tissue dependent. Materials with a higher
electron density will attenuate more [9]. Due to the L term,
smaller objects will tend to have a higher mean dose at the
isocenter because of the shorter path length between the
center and outside air, but still have a lower total absorbed
dose because of the shorter total path length [10].
Beyond this conceptual relationship, there are many sources
of noise in X-ray systems that must be considered in practice to
achieve the desired image quality for a given application. The
simplest explanation based on statistics (SNR ∝ √N, where
SNR is the signal to noise ratio andN is the number of photons)
dictates that dose must increase as the total number of pixels
increases to maintain a given per-pixel SNR. More complex
models that incorporate a full set of system parameters have
shown this to be true [11]. Therefore, guidelines exist to
navigate the different tradeoffs (e.g., [12]). In practice, one of
the best ways to design imaging protocols is to use phantoms to
find the right balance between an acceptable SNR, resolution
and dose with the overarching principal of using a dose as low
as reasonably achievable (ALARA) [5, 13–16].
Understanding the biological response to radiation is
obviously crucial to design longitudinal studies that require
ionizing radiation. Fortunately, a number of excellent reviews
have been written on the molecular mechanisms governing the
response. X-rays can interact with any molecule and, therefore,
can cause both short-term and long-term harm. X-ray interac-
tions with water can create reactive oxygen species (ROS) and
free radicals which have a number of potential effects on
cellular behavior [17]. X-rays can also interact with genetic
material and can directly induce damage foci that can be
detected with markers such as ATM (ataxia telangiectasia
mutated), 53BP1 (p53 binding proten 1), and γH2AX (a
phosphorylated version of histone H2AX) [18]. ATM and
γH2AX are part of complex signaling cascades leading to DNA
repair by homologous recombination (HR) or non-homologous
end-joining (NHEJ) processes [19, 20], and these signaling
cascades can also be impacted by micro-RNAs [21]. Even low-
dose radiation hypersensitivity (defined as doses below 0.3 Gy)
can affect both DNA repair and the cell cycle [22]. Therefore, it
is not surprising that μCT scans with doses as low as 150 mGy
in mice have been reported to induce double-strand DNA
breaks [23]. Fortunately, some of these double-strand breaks
will start to repair in the initial minutes post radiation and may
be largely repaired within the first day, although immune
competent C57Bl/6 mice repair more damage than severe
combined immune deficient (SCID) mice [23, 24]. Disruptions
to the HR and NHEJ signaling cascades or processes could
alter these rates.
For preclinical X-ray imaging, it is generally believed that
the LD50/30 (the dose lethal to 50 % of the subjects within
30 days) for rodents is in the range of 5–7.6 Gy [11], although
this may be reduced to 3 Gy in SCID strains [25].
Radiosensitivity is also dependent on animal strain [26]. Given
the complex interplays between physics and biology outlined
above, even formal animal welfare guidelines do not provide
actual numbers and simply state that doses should be
minimized [27]. It is important to look at dose on a tissue by
tissue basis and, in some cases, on a study by study basis to
understand the potential acute and longer-term impacts.
Dose Effects: Lung Applications
Lung tissue may not be particularly susceptible to the high
doses common in conventional fractionated radiotherapy and
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frequent μCT scanning. Immunocompetent C57/Bl6 mice
scanned three times per week for a 6-week period, with a
total cumulative dose of 5.04 Gy, do not have a difference in
lung parenchyma volume or Hounsfield unit (HU) value
[28]. Similarly, doses on the order of 5–12 Gy delivered to
the lung over 5 weeks, or 12 Gy over 12 weeks, do not result
in a change in aerated lung volume, lung tissue volume, total
lung volume, or gross histopathological change in immuno-
competent C57Bl/6 mice [29]. However, very high doses for
lung imaging could still be problematic. One week after
delivery of a 90 Gy dose to the lungs of immunocompetent
C57Bl/6 mice for sterotactic body radiotherapy there is no
noticeable change in gross morphology or lung structure on
a μCT image, although there is histopathological damage
that will eventually lead to fibrosis and altered lung function
as early as 2–3 weeks later [30]. The 30 Gy dose threshold
to induce this fibrosis in immunocompetent C57Bl/6 mice is
slightly lower for than the 50 Gy needed to induce fibrosis
for immunocompetent C3H mice [31]. A single 20 Gy dose
to the lungs of immunocompetent C57Bl/6 mice does not
cause a change in lung volume manually measured on a μCT
image after 4 days, but the HU value shifts and air spaces are
enlarged [32]. However, the simple image analysis methods
typically used for lung studies may not be adequate to detect
all of the changes that are visible in μCT images. A
variogram-based image analysis approach may be needed
to capture the effects of 6–15 Gy doses [33]. Most
importantly, since lung imaging is often used for cancer
studies, an investigator must keep in mind that specific
genetic mutations can have differential effects. As one
example, the presence or absence of a tumor suppressor
gene in mice impacts susceptibility to the difference between
a single 11.6 Gy dose and a fractionated 14.6 Gy dose
delivered over 2 days [34].
Dose Effects: Bone and Orthopedic Applications
Bone tissue has a higher linear attenuation coefficient than
soft tissues and experiences local doses approximately 3–5
times higher than lung tissue [29, 35, 36]. Therefore, many
studies have investigated the effects of ionizing radiation on
bone in a variety of environments. Within the context of a
radiation accident, a single 8 Gy dose of 60Co irradiation to
immunocompetent B6D2F1/J mice induces weight loss,
decreases trabecular bone volume fraction and reduces the
bone formation rate as long as 120 days post-exposure [37].
In the context of spaceflight, a 1–2 Gy dose of common
particles (gamma rays, protons, 12C6+, 56Fe26+) to immuno-
competent C57Bl/6 J mice decreases the trabecular bone
volume fraction and volumetric bone mineral density
(vBMD) over 110 days even though animal weight does
not change [38, 39]. Two Gy of gamma irradiation in C3H/
HeN mice decreases the trabecular bone volume fraction and
BMD as early as 12 weeks post-irradiation [40]. In contrast,
the delivery of 4.4 cGy to the appendicular skeleton (a
subset of the 60 Gy delivered to the head) of immunocom-
petent C57Bl/6 mice results in a remarkable increase in
trabecular BV/TV 11.5 months after exposure [41].
For X-ray radiation there are still potential issues for
normal μCT imaging protocols. Increased scan doses may be
required if high resolutions are needed for accurate bone
morphology measurements [42]. These doses can alter the
experimental outcomes. A 712 mGy dose delivered almost
weekly (1, 2, 3, and 5 weeks) to immunocompetent C3H/
HeJ, C57Bl/6J, or BALB/cByJ mice both with and without
ovariectomy (OVX) results in a trabecular BV/TV decrease,
but immunocompetent Wistar rats imaged every other week
do not show the same effect [43]. Similarly, imaging
immunocompetent Wistar rats weekly with a dose between
441 and 939 mGy over a 7-week period does not change the
trabecular BV/TV [44]. For mice, the time interval might be
more critical. One study reports a 30 % loss in trabecular
BV/TV of immunocompetent C57Bl/6 mice with three
776 mGy scans separated by 2-week intervals, but not when
the dose per scan was reduced to 434 mGy [45].
The radiation-induced changes detected in these μCT
imaging studies are probably reflective of phenomena that
are more systemic and cellular in nature. Single 15–20 Gy
doses of X-rays delivered to the abdomen of immunocom-
petent C57Bl/6 mice results in a BMD decrease in the femur
and tibia as early as 7 days post-radiation [46]. The same
study also reports a weight decrease 5–7 days after
irradiation, similar to other data indicating a significant
weight decrease in immunocompetent C57Bl/6 and BALB/c
SCID mice 3 days after a 3.36 Gy dose [23]. Both a 0.5 and
2 Gy whole body dose of X-ray radiation to immunocom-
petent C57Bl/6JJcl mice results in fewer bone marrow cells
as early as 1 day post-exposure [47], and a 2 Gy whole body
dose of X-rays to immunocompetent C57Bl/6 mice increases
osteoclast number as early as 3 day post-exposure [48].
Osteophytes can occur with a whole body dose as low as
3 Gy in immunocompetent Fisher F344 X Brown Norway
rats, and cartilage degradation worsens as dose increases
[49]. Localized dose delivery can also be problematic. Both
5 and 20 Gy of X-rays delivered to one limb of
immunocompetent Balb/c mice induces alopecia and ery-
thema, and results in a dose dependent decrease in trabecular
BV/TV 6 weeks post-irradiation [50]. Trabecular bone
volume losses in both irradiated and the non-radiated
contralateral tibiae 10 days after a 2 Gy dose of X-ray
radiation localized to the limb of immunocompetent C57Bl/6
mice is also associated with a body weight decrease
attributed to fat loss, increased marrow adiposity, increased
number of osteoclasts, and reduced bone formation rate [51].
Commercially available pharmaceuticals may be able to
help prevent the effects of radiation-induced bone loss from
X-rays. Treatment with the anti-catabolic bisphosphonate
risedronate results in an increased trabecular BV/TV 3 weeks
after a 2 Gy dose of X-rays to immunocompetent C57Bl/6
mice, even though the radiation alone reduces BV/TV and
vBMD as early as 1 week and decreases the bone formation
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rate starting at 2 weeks [52]. The anabolic agent parathyroid
hormone (PTH) 1–34 increases vBMD and BV/TV starting
4 days after treatment in immunocompetent Sprague Dawley
rats, even though the 0.48 Gy dose delivered during daily
imaging decreases vBMD and BV/TV without PTH [53].
Dose Effects: Oncology Applications
Damage from accumulated radiation is a particular concern
in cancer research, especially since longitudinal monitoring
is often essential for tracking tumor progression [34, 54–56].
Given that radiotherapy is a common approach for treating
cancer, it is not surprising that high local doses of radiation
can reduce tumor volume [57–59]. This must be done with
caution. Doses of 2–4 Gy of gamma radiation to hepatocel-
lular carcinoma cells in vitro can increase the stemness of
cancer cells after 7–14 days [60]. A single 30 Gy X-ray dose
delivered directly to a tumor causes a significant upregula-
tion of genes associated with angiogenesis and downregula-
tion of genes for eukaryotic initiation factors [61]. This may
be related to changes in vascularity. A single 20 Gy dose of
X-ray radiation to sarcomas in transgenic mice increases the
fractional blood volume and dextran accumulation within a
sarcoma after just 4 days [57]. This is about the same
timepoint at which vasculature within a tumor begins to
reform [61]. The MET oncogene is upregulated in vitro by a
10 Gy dose of X-rays with the resulting cells being able to
migrate easier [62]. A 5 Gy dose to subcutaneous tumors
implanted in athymic nude mice may be sufficient to induce
DNA damage in a tumor and induce a growth delay [59].
However, a 3 Gy dose of X-rays delivered locally to
xenografts implanted in nonobese diabetic–severe combined
immunodeficient (NOD/SCID) mice results in a significant
weight loss by the 5th day post-irradiation [58], and 3–
10 Gy of X-ray radiation to cancer cells in vitro may induce
tumor cells to repopulate [63].
Lower radiation doses that are more common in imaging
procedures can also be problematic. X-ray doses as low as
0.25–2 Gy induce intestinal and colon tumors in genetically
prone immunocompetent mice in an age and strain-
dependent fashion [64]. Doses as low as 0.3–0.5 Gy to
human microvascular endothelial cells (HMVEC) can
induce molecular markers of vascular formation, especially
in a simulated hypoxic environment, and this can lead to
increased angiogenesis in athymic swiss Nu/Nu mice and an
increased tumor burden 14 days later in an orthotopic NOD/
SCID murine model [65]. Performing a ~ 1 Gy scan in a
metastatic tumor model using athymic nude mice once
weekly over a 5-week period increased leg metastasis and
the histological tumor area nearly two-fold [56]. Conversely,
although high-resolution scans may kill tumor cells, when
the imaging protocols are designed to manage dose there
may not be a detrimental effect on bone tumor growth with
weekly scans of athymic nude mice over a 4-week study
[54]. Doses of 0.07–0.30 Gy every 4 days during a routine
imaging procedure also do not change the volume of
subcutaneous tumors implanted in immunocompetent
C57Bl/6 mice after 16 days [55].
Radiation effects on the immune system may also need to
be considered in oncology studies utilizing μCT imaging.
Many preclinical oncology studies use SCID mice which
have increased radiosensitivity and a defective DNA repair
mechanism [26, 66]. Tumors derived from SCID mice are
more susceptible to high doses of radiation than tumors
derived from C3H mice [25], which may be related to
endothelial biology [67]. Conversely, translational oncology
studies that use immunocompetent rodent strains are
becoming increasingly important as immunotherapies that
impact NK, T, and B cells of the immune system gain
traction [68]. Individual cytokines like IL-1β that are
relevant in immune system signaling may be upregulated
by high doses of X-ray radiation [69]. At doses more
relevant to in vivo μCT imaging, 0.1 Gy of 80 kVp X-ray
radiation significantly alters gene regulation in these
immunological pathways [70]. Immunologically relevant
cytokines and the cytolytic activity of NK cells and
macrophages is also increased in response to a single dose
of 0.1 or 0.2 Gy of X-rays, which can potentially act as a
radioprotectant by reducing subsequent tumor burden [71].
Dosimetry Methods
Given these complicated effects and interactions, it is clearly
important to have a precise understanding of radiation dose
within a scan. In clinical environments, several standards
have been implemented to ensure reproducibility and patient
safety [72–75]. Unfortunately, there is no similar standard
for preclinical research. A number of different techniques
have been applied in the literature. The simplest and most
widely accepted approach is to use an ionization chamber
[10, 13, 28, 29, 33, 39, 43–45, 55, 58, 76–79]. This data can
then be used to calculate the CT dose index (CTDI100) as is
commonly done in clinical environments. Gafchromic films
can be used to develop a depth profile if more detailed
information is needed [14, 23, 61, 80]. Others have
implanted thermoluminescence dosimeters (TLDs) or
nanoDots near specific organs within an animal to measure
the doses at specific locations [14, 29, 42, 76, 77, 81–87].
The most complete map of dose in every tissue requires
Monte-Carlo-based simulations, although the implementa-
tion complexity and variability in the results makes these
techniques challenging to reproduce [10, 29, 35, 36, 76].
In light of the complex relationships between dose and
experimental outcomes, to help guide proper study design
and application of μCT imaging methodologies, the purpose
of this work is to characterize dose on the Quantum GX and
provide a framework for protocol selection. Ionization
chambers are used to measure the dose at the center of x-
ray beam and CTDI100 on the rotation axis. The results can
be appropriately used in a translational context. Doses from
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other μCT imaging systems will also be described to provide
some context for where this newer system compares with
other scanners used in the scientific literature.
Experimental Design and Methods
Scanner Configuration
The Quantum GX uses a complementary metal-oxide semicon-
ductor (CMOS)-based flat-panel detector. Various imaging
modes within the scanner enable this to be used with bin modes
of 1, 2, or 4. The flat panel detector is mounting on an adjustable
magnification mechanism which, in turn, is mounted on a
rotating gantry. This adjustable magnification mechanism allows
the source to object distance to be modified, enabling a broader
range of applications to suit both high-resolution and low-dose
applications. The source to detector distance is fixed. The actual
distances and detector specifications are reported in Table 1.
The microfocus X-ray source in this scanner is limited to
a maximum voltage of 90 kVp and a maximum power of
8 W. The X-ray source uses a Tungsten anode. A fixed filter
of 0.5 mm Al and 0.06 mm Cu is placed in front of the exit
port to remove low energy X-rays that contribute to dose but
do not improve image quality.
Half Value Layer Measurements
The half value layer (HVL), defined as the thickness of
aluminum that reduces the radiation energy by 50 %, was
measured to get a sense of the X-ray beam quality. A meter
was placed at isocenter of the X-ray beam on a sample bed
normally used for rat imaging (Piranha 657, RTI Electronics
AB). Data were measured for voltage settings of 50, 60, 70,
80, and 90 kVp. Both the measured voltage and half value
layer were reported.
Dosimetry Measurements
Two cylindrical phantoms were made from polymethyl
methacrylate (PMMA) with outer diameters of 20 and
32 mm (Fig. 1a) to mimic attenuation from a mouse and
rat, respectively, similar to previously reported studies [76].
The inner diameter of 12.54 mm was made to fit the 10-cm-
long pencil ionization chamber used for dosimetry
measurements. The phantom length was 15 cm to be
consistent with clinical dosimetry practices [75].
To make the measurements, the ionization chamber was
either placed directly on the sample bed or slid into the
phantom before being centered on the sample bed. The sample
bed was then moved so that the center of the ionization
chamber was aligned with the z-center of the X-ray beam
(Fig. 1b). A dose measurement was then made for a fixed tube
power of 7.9 W at voltage of 50, 70, or 90 kVp. Measurements
were made in triplicate and the mean value was used for
reporting doses. A schematic set-up for the dose measurement
in low magnification scanning mode is shown in Fig. 1c.
A Thimble chamber (Model 10 × 5–0.6CT, Radcal Inc.,
Monrovia, CA, USA) was used to measure the dose at the center
of the x-ray beam on the rotation axis. The chamber has an active
length of 21 mm and an active volume of 0.6 cm3. A pencil
ionization chamber (Model 10X5-3CT, Radcal Inc., Monrovia,
CA, USA) was used to measure CTDI100 on the rotation axis.
Both chambers have flat energy response with about 4 %
variation over half value layers (HVL) between 1.6 and 10 mm
of aluminum (Radcal Calibration Laboratory Personal Commu-
nication) Each chamber was connected to a dosemonitor (Model
9015, Radcal Inc., Monrovia, CA, USA) for reading out. The
calibration of the dosimeter system was traceable to the National
Institute of Standards and Technology (NIST).
CTDI100 Calculation
Once the raw measurements were completed, CTDI100 was





where N is defined as the number of slices, T is defined as
the slice thickness at ISO, and D(z) is the dose profile along
the z-axis (Fig. 1c). The product of N*T is effectively the
beam width in the z-direction at the isocenter. Because the
ionization chamber measures an average exposure (in units
of mR), the f-factor was included to convert the exposure to
the actual absorbed dose in air (in units of rad) and
converted into mGy. CTDI100 measurements were then
normalized to mA × s based on the acquisition times. The
f-factor of 0.87 rad/R was used [74]. Even though this value
is noted for 120 kVp, the same value will be used for the
softer beams here because the responses are almost constant
with respect to energy [88].
Image Acquisition and Analysis for Application
Examples
Images of mice and phantoms were obtained to study the
relationship between dose and image quality. For animal
Table 1. Specifications of the Quantum GX imaging system that are used
in CTDI100 calculations
Specification Value
Detector pixel pitch 49.5 μm
Number of rows on detector (z-axis) 2352
Number of columns on detector (x, y-axes) 2944
Source to detector distance (SDD) 203 mm
Source to object distance (SOD), high
magnification (36mm acquisition FOV)
55 mm
SOD, low magnification (72 mm acquisition FOV) 108 mm
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images, 7-month old immunocompetent female BALB/c
mice were used. One mouse was scanned at peak X-ray
tube voltages of 50, 70, and 90 kVp for the shortest scan
time using the low magnification. A second mouse was
scanned at 90 kVp using all available scan times applicable
for in vivo imaging, and then a single slice was
reconstructed at the highest allowable resolution. A ring
reduction correction was applied to the sinograms, and the
resulting corrected sinograms were input into a GPU-based
filtered-backprojection reconstruction algorithm using a
Ram-Lak filter. Images were then imported into Analyze
12.0 (AnalyzeDirect, Overland Park, KS) and calibrated to
be on the Hounsfield unit (HU) scale. A segmentation map
was created using semi-automatic segmentation tools to
select voxels of bone, adipose tissue, lung parenchyma,
and general soft tissue (areas of the GI tract containing
food were excluded). This segmentation map was then
applied to each image to calculate the mean HU value for
each tissue type. The contrast to noise ratio (CNR) was
also calculated for each tissue type. Contrast was defined
as the difference between the mean value of tissue and the
mean grayscale value of the animal bed. Noise was defined
as the standard deviation of air. All experiments were done
under the approval of an institutional animal care and use
committee.
Two separate phantoms were also scanned at a peak X-
ray tube voltage of 90 kVp to explore the relationships
between dose and image quality. The first phantom was a
32 mm diameter low contrast phantom that contains 1 and
2.5 mm diameter rods embedded in resin at an approximate
contrast 4 and 8 % HU (QRM-MicroCT-LC, QRM GmBH,
Möhrendorf, Germany). The second phantom was a 32 mm
diameter hydroxyapatite (HA) phantom typically used for
bone mineral density calibrations that contains materials
equivalent to 0, 50, 200, 800, and 1200 mg/cm3 of HA
embedded in resin (QRM-MicroCT-HA, QRM GmBH,
Möhrendorf, Germany). The scan times were selected to be
both 18 s and 2 min, two protocols in the Quantum GX
which use a 2 × 2 detector binning mode. A ring reduction
correction was applied to the sinogram, and the resulting
corrected sinogram was input into a GPU-based filtered-
backprojection reconstruction algorithm using a Ram-Lak
filter to create the 3D images. Images were then imported
into Analyze 12.0, calibrated to be on the HU scale, and
visualized.
Results
Quantum GX Dose Measurements
Half value layer measurements ranged from 1.56 mm Al
for 50 kVp up to 2.6 mm Al for 90 kVp (Table 2). The
HVL measurements increase as a function of peak X-ray
source voltage. As confirmed by the dosimeter vendor
Radcal, the energy dependency of the ionization chambers
is flat in the measured HVL range with a maximum
variation of 4 %.
The measured CTDI100per mAs at the center of x-ray
beam on the rotation axis are shown in Table 3. For both the
low- and high-magnification modes, the difference between
the measured CTDI100 in air, in the mouse phantom, and in
the rat phantom is less than 13 % for a given kVp setting.
Interestingly, for 90 kVp with the low magnification, the
dose rate increased slightly in comparison to air when the
mouse phantom was used but decreases again when the rat
phantom was used. Dose rates are also a function of the peak
X-ray voltage. The CTDI100 for 70 kVp are 36–40 % lower
than at 90 kVp. The CTDI100 for 50 kVp are 70–73 % lower
than at 90 kVp. The middle point dose in air was measured
at 7.0 mGy/mA*s for a 70 kVp beam and 11.8 mGy/mA*s
for a 90 kVp beam.
For the shortest 8-s scan time on the Quantum GX, at
90 kVp the dose floor (defined as the lowest possible dose
for a particular configuration) is 39.8 and 9.9 mGy,
Fig. 1 a PMMA phantoms placed around the ionization chamber for measuring doses relative to a mouse and rat. b Front view
of dose measurement set-up in low magnification mode showing the system geometry listed in Table 1. c Side view of dose
measurement set-up in normal mode. The total x-ray beam width at rotation axis is defined as N × T × SOD/SDD, where the
parameters are defined in Table 1. For the low magnification mode shown here this equates to 0.0495 × 2352 × 108/
203 = 61.94 mm. For the high magnification mode (not shown) this equates to 0.0495 × 2352 × 55/203 = 31.543 mm.
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respectively, for the high and low magnifications in air.
The dose floor reduced slightly to 9.4 mGy when the
32 mm PMMA phantom was used. Reducing the tube
voltage to 50 kVp changes the dose floor to 21.0 and
5.1 mGy, respectively, for the high and low magnifications
in air.
Application Examples
A series of example images were acquired to provide context
for interpreting how dose may impact applications. For
screening applications that typically use the low-dose
protocols, a single mouse was scanned using a range of
common X-ray source voltages. A segmentation map of
bone, adipose tissue, soft tissue, and lung parenchyma were
created and applied to each of the images (Fig. 2). There is
an increase in contrast of bone as the voltage decreases
(Table 4). There was no measureable change in HU value as
a function of voltage for adipose tissue, soft tissue, or lung
parenchyma. The noise level and CNR did change slightly
for soft tissue and lung parenchyma as a function of voltage.
There were changes for bone applications that typically
require high resolution and necessitate higher doses, a single
mouse was scanned using a range of scan times and the best
resolution image possible for each scan time was recon-
structed (Fig. 3). There is a significant increase in anatomical
detail as the scan time increases and as the physical
magnification increases.
To provide an example of how dose relates to image
quality for a given detector bin mode, voltage and physical
magnification, two separate phantoms were scanned. In a
low-contrast phantom, a 1 mm insert with an approximate
HU contrast 4 % was not visible with a 18-s scan but was
visible with a 2-min scan (Fig. 4a, b). All other rods in the
phantom were much easier to visualize when the scan time
increased. For a HA phantom that contains a range of
mineral density equivalents, all four inclusions containing
HA could be easily visualized at both scan times (Fig. 4c, d).











50 158 7.90 49.57 1.56
60 133 7.98 60.24 1.71
70 114 7.98 70.18 1.96
80 100 8.00 79.93 2.26
90 88 7.92 89.35 2.60
Table 3. Dose rate measurements on the Quantum GX μCT imaging system
Magnification Environment CTDI100 measurements (mGy/mA*s)
50 kVp, 158 uA (7.90 W) 70 kVp, 113 uA (7.91 W) 90 kVp, 88 uA (7.92 W)
Low (72 mm FOV) Air 3.49 7.72 12.07
20 mm PMMA (mouse) 3.38 7.33 12.21
32 mm PMMA (rat) 3.12 6.89 11.48
High (36 mm FOV) Air 14.31 30.07 48.65
20 mm PMMA (mouse) 13.74 29.53 47.57
32 mm PMMA (rat) 12.45 27.68 45.54
Fig. 2 Example coronal slices showing the shortest 8-s scan
using the low magnification for peak X-ray source voltages
and doses of a 50 kVp and 5.0 mGy with a noise level of
38 HU, b 70 kVp, and 7.8 mGy with a noise level of 34 HU,
and c 90 kVp, and 10.0 mGy with a noise level of 32 HU.
Doses were calculated using the CTDI100 measurements for
the mouse equivalent phantom. d The bone (red), lung
parenchyma (yellow), adipose tissue (green) and soft tissue
(blue) were segmented, and the mean grayscale values for
each mask were calculated (Table 4). The GI tract was
specifically excluded because chow could potentially bias
the soft tissue grayscale value. All images are displayed with
a level of 750 HU and a window of 2500 HU, and filtered with
a 3 × 3 ×3 low pass filter to reduce noise.
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Dose from Other Scanners
In order to have context for the dose data for the Quantum
GX imaging system, a literature review was performed to get
a sense of the doses reported for other similar instrumenta-
tion (Table 5). Dosimetry methodologies vary and can have
considerable impact on how the dose is reported, so the
methods used are noted along with the data. Many
instruments have a wide range of doses reported because
there is considerable flexibility in how the system is used. A
dose floor below 10 mGy is reported for two instruments
(BioScan nanoSPECT/CT and Aloka LaTheta LCT-200),
below 100 mGy for five instruments (GammaMedica X-O,
GE CT120, GE Locus Ultra, Imtek MicroCAT II, Siemens
Inveon), and above 100 mGy for three instruments (ScanCo
vivaCT40, Skyscan 1076, Skyscan 1178) (Table 4). Com-
paring performance between systems is difficult because of
differences in system design and the lack of a standardized
approach. Therefore, the primary application for each
publication was collated. While there is a considerable range
of doses, orthopedics applications generally have higher
doses while applications in general radiology for soft tissue
screening typically have lower doses. It should be noted that
other systems are available and that various manufacturers
Table 4. Grayscale values in HU (mean ± sd) and CNR for the images shown in Fig. 2
Tissue type 50 kVp 70 kVp 90 kVp
Grayscale / CNR Grayscale CNR Grayscale CNR
Adipose –23 ± 96 –1.7 –40 ± 74 –2.4 –42 ± 71 –2.4
Soft tissue 159 ± 84 3.0 116 ± 68 2.2 92 ± 62 1.7
Lung parenchyma –275 ± 80 –8.3 –298 ± 79 –9.9 –308 ± 77 –10.6
Bone 2118 ± 650 54.3 1623 ± 502 46.4 1339 ± 438 40.4
Fig. 3 Example images of a transaxial rostral slice through L6 showing subvolume reconstructions at the highest resolution
possible. a The low magnification was then cropped (yellow box) for display purposes to show the b 8-s scan, 36 μm isotropic
voxel size, 10 mGy, c 18-s scan, 18 μm isotropic voxel size, 22.4 mGy, d 2-min scan, 18 μm isotropic voxel size, 130.4 mGy, or
e 4-min scan, 9 μm isotropic voxel size, 269.1 mGy. f The high magnification was then cropped (box) for display purposes to
show the g 8-s scan, 18 μm isotropic voxel size, 38.9 mGy, h 18 s scan, 9 μm isotropic voxel size, 87.1 mGy, i 2-min scan,
9 μm isotropic voxel size, 508.2 mGy, or j 4-min scan, 4.5 μm isotropic voxel size, 1048.2 mGy. All images are displayed with a
level of 1000 HU and a window of 4000 HU with no filtering applied.
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may have different data than what is presented here. The
data reported in Table 5 is based solely on peer-reviewed
publications.
Discussion
The lowest dose preclinical systems use doses on the same
order of magnitude as the 1–10 mSv values typically
reported in clinical CT [89]. These doses are considered to
be manageable in longitudinal studies. For example, scan-
ning mice three times weekly for a 4-week period with a
16 mGy protocol does not impact body weight, organ
weights, or hematological readouts either acutely or when
followed by a 4-week latency period [79]. The dosimetry
data presented in this study indicate that the Quantum GX
has a dose floor that is also within the range of clinical CT
systems. For the typical ‘recommended’ voltage of 90 kVp,
although there is a wide range of possible doses depending
on the imaging mode chosen, the lowest dose is 9.9 mGy.
This is similar to two other instruments showing doses
below 10 mGy and, in itself, is a conservative estimate
because it is based solely on the air kerma rate. The PMMA
phantom results indicate that the dose may decrease slightly
when mice or rats are scanned. The slight increase in
CTDI100 in the low magnification when switching from air
to the mouse PMMA phantom may indicate a slight increase
in scatter that is then absorbed when the thicker rat PMMA
phantom is used.
HVL data for the Quantum GX is comparable to the
2.5 mm Al HVL of another preclinical μCT system that uses
a 80 kV beam [81]. More importantly for this study, this
range is consistent with other radiographic imaging equip-
ment, so ionization chambers are generally applicable. Doses
for the lower energies (50 and 70 kVp) may be up to 4 %
underreported because the typical clinical CT systems have a
slightly higher typical HVL [90], but for HVL values above
approximately 2.0 (80–90 kVp) the dosimetry data can be
considered accurate. This is reinforced by the similarity
between the thimble chamber measurements and the ioniza-
tion chamber measurements. The dose floor of the Quantum
GX is also consistent with other preclinical instrumentation.
Direct head to head comparisons between the various
preclinical instruments are quite difficult because the system
designs differ widely. Differences between the instruments
in physical geometry, X-ray beam quality, and operating
modes (voltages, scan times, etc.) all have a significant
effect on dose. Differences in the detective quantum
efficiency due to the scintillator, optical coupling, and
sensor type (e.g., charge-coupled device (CCD), CMOS,
amorphous Si) also significantly impact how the radiation
dose affects image quality in a projection image. Recon-
struction implementations including the type of algorithm
(e.g., filtered backprojection, iterative) and filter kernel also
impact the quality of the reconstructed 3D image. However,
the comparative data available in the literature still provide a
valuable reference point for understanding what is common
within preclinical imaging.
Some preclinical applications may be achievable with
low-dose protocols, but some applications may require
higher-dose imaging protocols. For general whole body
screening, the Quantum GX provides excellent image
quality with the lowest dose 50, 70, and 90 kVp protocols.
The decrease in contrast for bone tissue in a mouse as the X-
ray source voltage increases is consistent with reduced
attenuation as the HVL increases. The lack of measurable
changes in contrast of adipose tissue, soft tissue, and lung
parenchyma as a function of voltage suggests that the HVL
may need to be reduced further to increase contrast for these
tissues. Alternatively, as demonstrated using a low-contrast
phantom, switching to a higher-dose acquisition protocol can
help improve the contrast to noise ratio for visualizing low-
contrast structures. However, the ability to visualize bone
and HA at 90 kVp indicates that low-dose acquisitions may
be sufficient for some applications. However, if skeletal
morphology needs to be measured, using a higher-dose
protocol can substantially improve the ability to resolve
small structures [42].
There are also applications specific approaches for gating
in cardiopulmonary imaging that can affect dose. Prospec-
tive gating methods theoretically have equivalent dose to
Fig. 4 Comparisons of a, b a low contrast phantom
displayed with level of 0 HU and a window of 400 HU and
c, d a HA phantom displayed with a level of 1000 HU and a
window of 3000 HU. The images were acquired with either a,
c an 18 s, 22.4 mGy scan or b, d a 2 min, 130.4 mGy scan
using 2 × 2 binning on the detector, a 90 kVp X-ray source
voltage and the low physical magnification. Increasing the
dose by increasing the scan time enables visualization of all
four inclusions in the low contrast phantom. All four
inclusions were visible in the HA phantom at either scan time.
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ungated protocols, although the dose for respiratory appli-
cations may still increase approximately 25 % in practice
[78]. This is still much lower than retrospective methods that
require oversampling and increase dose in comparison to
prospective methods [91]. However, this is often acceptable
because the retrospective methods will work for variable
respiration rates, whereas prospective methods assume that
the respiration interval is constant during the entire scan. The
only way to ensure that dose for ungated and gated
acquisitions are identical is to intubate and mechanically
ventilate so that the same protocol can be used [92]. Cardiac
gating methods face similar challenges, although the dose
for cardiac gated acquisitions can also be lowered if image
analysis approaches are designed that are robust against the
image quality reductions which occur [93].
There are several possible approaches to reducing dose in
the future versions of the Quantum GX. First, because this
dose is for an operating mode where data is acquired over
360 degrees, optimizations to use a half scan protocol could
reduce this even further [94]. Second, the data presented
here suggest that the dose could be reduced quite
considerably by switching from 90 kVp to lower voltages
and still provide excellent image quality for certain
applications. Although the expected gain in soft tissue
contrast was not obvious for the shortest 8-s scan time,
50 kVp has been used using the earlier generation Quantum
FX for adipose imaging [95], so the lower voltages may still
be useful for soft tissue quantification. Further optimizations
of the X-ray filters that either reduce the HVL and increase
soft tissue contrast, or increase the HVL and further reduce
dose, are also plausible. There are also several software
improvements that can potentially reduce dose. Clinical CT
systems now use fairly sophisticated image reconstruction
algorithms, but most μCT systems still use variations of the
filtered-backprojection methods initially reported several
decades ago [96]. Recent research indicates that more
advanced reconstruction methods can be employed which
allow the number of projections to be reduced, thereby
reducing the required X-ray dose [97, 98].
In the clinical CT environment, the Image Wisely® and
Image Gently® initiatives help ensure that the ALARA
principle is followed [99, 100]. However, there is no similar
Table 5. Dose measurements for μCT imaging systems reported in the peer-reviewed literature
CT instrument Dosimetry methods Imaging application Area Doses reported Ref.
BioScan nanoSPECT/CT EBT2 gafchromic films Multi-modality, oncology 8.3–3361 mGy [23]





General 153–200 mGy [76]
Gamma Medica X-O (Not reported) Pulmonology 63.6 mGy [91]
Gamma Medica X-SPECT/CT (not reported) Multi-modality, oncology ~1000 mGy [56]
Gamma Medica X-SPECT/CT LiF TLDs Oncology 14–134 mGy [85]
GE CT120 CTDI100 (MOSFET) General 20.15–56.79 mGy [101]
GE CT120 Monte Carlo simulations General Whole body, mouse: 67–189 mGy
Whole body, rat: 42–119 mGy
[36]
GE eXplore Locus LiF TLDs General 126–229 mGy [87]
GE Locus Ultra Ionization chamber General 64–270 mGy [13]
GE Locus Ultra Ionization chamber Oncology 69–296 mGy [55]
GE RS—90 Ionization chamber Pulmonology Ungated: 120 mGy
Gated: 150 mGy
[78]
Imtek MicroCAT TLDs Oncology Organs: 210–760 mGy [86]
Imtek (Siemens) MicroCAT II LiF TLDs
ionization chamber
General Air: 78–97 mGy
Organ: 65–86 mGy
[81]
Imtek (Siemens) MicroCAT II NanoDot General 11–104.5 mGy [83]
Imtek (Siemens) MicroCAT II TLDs General Air: 55.6–61.5 mGy [84]
LaTheta LCT—200 TLDs Contrast agents 5–40 mGy [15]
Rigaku RmCT2 (PerkinElmer
Quantum FX)
FGDs General 16 mGy [79]
ScanCo vivaCT40 Ionization chamber Whole body scanning (mice) Polymer: 712.4 mGy
Air: 845.9 mGy
[43]
ScanCo vivaCT 40 CTDI (ionization chamber) Orthopedics Air: 939 mGy
Polymer: 441 mGy
[44]
Siemens Inveon TLDs Orthopedics 40–1257 mGy [42]
Siemens Inveon NanoDot General Organs: 9.4–163.1 mGy [83]
Skyscan 1076 (Not reported) Orthopedics 400 mGy [102]
Skyscan 1076 Ionization chamber
TLDs
Monte Carlo
Pulmonology Ionization chamber: 1640 mGy
TLDs, skin: 1104 mGy
TLDs, lung: 813 mGy
Monte Carlo, organs: 900 mGy–4.5 Gy
[29]
SkyScan 1076 Ionization chamber Orthopedics 166, 434 or 776 mGy [45]
Skyscan 1178 CTDI100 (ionization chamber)
LiF TLDs
General Organs: 295–507 mGy [77]
X-Strahl SARRP (Not reported) Radiotherapy planning 16, 32 or 64 mGy [103]
Custom dual energy system Not reported-data unpublished Oncology 260 mGy [57]
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initiative or any widely accepted standard in the preclinical
research environment. Investigators must find an acceptable
image quality (e.g., SNR, spatial resolution) that can be
achieved with the lowest possible dose for each experiment.
Specific experimental variables should be considered when
designing any μCT study including (but not necessarily
limited to) the following:
 Animal strain: Some strains have a higher radiosensitiv-
ity. Given that some animal models require specific mice
strains and/or necessitate the use of immune deficient
animals, any concerns specific to the strain should be
tracked during the study.
 Animal gender and age: The biological response to
radiation-induced damage is mediated by molecular
pathways. There is experimental evidence of age specific
responses to ionizing radiation, so it is worth considering
both in study design.
 Tissue of interest: Local absorbed doses can vary
significantly from tissue to tissue. While a particular dose
may not necessarily affect one tissue (e.g., lung), it may
have an impact on other tissues that absorb more local
dose (e.g., bone) and both tissue types are usually
exposed to radiation during a scan.
 Imaging timepoints: Some radiation-induced damage can
be repaired at the molecular level. Therefore, the
frequency of imaging should be considered carefully
and minimized as much as possible within the context of
a particular experimental hypothesis.
 Outcome metric: Some purely anatomical measurements
may be less correlated to radiation-induced damage.
However, damage may still be occurring at the cellular
and molecular levels. This may be acceptable in some
studies, but should be considered carefully particularly
when a molecular-based pathology is being studied and/
or when subsequent research will require investigating
cellular and molecular mechanisms. This should also be
considered carefully when pathologies which are inher-
ently systemic (e.g., metastatic cancer) are being
investigated.
Conclusions
In conclusion, μCT imaging techniques are invaluable in
many research studies and have been widely used. The
Quantum GX imaging system has a beam quality compara-
ble to other μCT imaging systems and provides range of
protocols which enable a wide range of possible radiation
doses. Selecting the best imaging protocol is not trivial.
Doses can be chosen which are quite low to avoid any
radiation damage, but some applications will require higher
doses. There is some conflicting data in specific studies, but
the complex downstream effects of radiation-induced dam-
age make it important carefully manage radiation doses
when using these techniques. Simple metrics like body
weight are important to track and may uncover some
underlying systemic changes when frequent longitudinal
imaging is required. Including additional experimental
groups with a significantly reduced radiation exposure can
also provide some assurance that the radiation dose effects
do not adversely impact interpretation of the data. When all
of these considerations are properly balanced, μCT-based
imaging techniques can be properly managed to provide all
the benefits of in vivo imaging.
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